News Detail | Only Chemical

JB Chemicals gets USFDA nod to market generic medication

22, December 2023 272

JB Chemicals & Pharmaceuticals on Wednesday said it has received approval from the US health regulator to market a generic product, used to treat mood disorders, in the American market.

The company has received approval from the US Food and Drug Administration to market Doxepin Hydrochloride capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, JB Chemicals & Pharmaceuticals said in a regulatory filing.

The company's product is the generic version of Pfizer's Sinequan capsules which are indicated for the treatment of anxiety, depression, and other target symptoms of psychoneurosis.

The drug will be manufactured at the company's formulation manufacturing facility in Panoli, Gujarat, the drug maker noted.

What are you looking for ? Let our experts help you

Browse by Chemical Keyword Alphabetically

Supplier Index

A	B	C	D	E	F	G
H	I	J	K	L	M	N
O	P	Q	R	S	T	U
V	W	X	Y	Z

Compound Index

A	B	C	D	E	F	G
H	I	J	K	L	M	N
O	P	Q	R	S	T	U
V	W	X	Y	Z

CAS Index

1	2	3	4	5	6	7
8	9

Country Index

All	A	B	C	D	E	F
G	H	I	J	K	L	M
N	O	P	Q	R	S	T
U	V	W	X	Y	Z

Explore

All Categories

All Categories

JB Chemicals gets USFDA nod to market generic medication

Other Post

What are you looking for ? Let our experts help you

Have Questions ? Procurement Help ? Email:info@onlychemicals.com